Laurion Capital Management LP Werewolf Therapeutics, Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$3.92 - $7.91 $478,330 - $965,201
122,023 Added 154.04%
201,236 $1.3 Million
Q4 2023

Feb 14, 2024
SELL
$1.78 - $4.15 $789,762 - $1.84 Million
-443,687 Reduced 84.85%
79,213 $305,000
Q3 2022

Nov 14, 2022
SELL
$4.14 - $7.42 $50,756 - $90,969
-12,260 Reduced 2.29%
522,900 $2.36 Million
Q2 2022

Aug 15, 2022
BUY
$3.43 - $5.98 $1.84 Million - $3.2 Million
535,160 New
535,160 $2.19 Million

Others Institutions Holding HOWL

# of Institutions
69
Shares Held
31.8M
Call Options Held
700
Put Options Held
500
View Full List

About Werewolf Therapeutics, Inc.

HOWL Quotes by TradingView
  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $47M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email